DURHAM, N.C.--(EON: Enhanced Online News)--Bioventus, a global leader in orthobiologics, today announced that a published study reveals its latest generation EXOGEN Ultrasound Bone Healing System improves patient compliance by 10% and overall compliance never fell below 76%. EXOGEN uses safe, effective low-intensity pulsed ultrasound (LIPUS) to help stimulate the body’s natural healing process.1 The findings are published in the November 30, 2016 issue of Medical Devices: Evidence and Research available here.
“The work also revealed that use of the next generation EXOGEN device resulted in a measurable improvement in patient adherence, which may help to optimize clinical outcomes and fracture healing. LIPUS technology can make a difference if it used as directed.”
The next generation EXOGEN device launched in 2014 and features a compliance calendar. The study found that among 12,984 patient data files analyzed, the patient compliance was 84%, while compliance with the previous generation EXOGEN device was 74%. In addition, incorporation of the calendar feature resulted in compliance never decreasing below 76% over the 6-month analysis period.
The researchers also analyzed 12 clinical trials on LIPUS where compliance was recorded. In eight of these clinical studies, where they met their end point, compliance was 88%. If the primary end point was unmet, compliance averaged 54%.
“This study clearly shows a correlation between clinical effectiveness and compliance rates of more than 70%,” said Neill Pounder, Director – Project Management, Bioventus. “The work also revealed that use of the next generation EXOGEN device resulted in a measurable improvement in patient adherence, which may help to optimize clinical outcomes and fracture healing. LIPUS technology can make a difference if it used as directed.”
Authors of this study are N.M. Pounder, J.T Jones and K.J. Tanis of Bioventus.
Bioventus is an orthobiologics company that delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. Bioventus has two product portfolios for orthobiologics, Bioventus Active Healing Therapies and Bioventus Surgical that make it a global leader in active orthopaedic healing. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide.
Bioventus, the Bioventus logo and EXOGEN are registered trademarks of Bioventus LLC.
1. Azuma Y, Ito M, Harada Y, Takagi H, Ohta T, Jingushi S. Low-intensity pulsed ultrasound accelerates rat femoral fracture healing by acting on the various cellular reactions in the fracture callus. J Bone Miner Res. 2001; 16(4):671-680.